ABBV
AbbVie Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+45/100
Last price
266.69
▲ 0.93 (0.35%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
265.66
Prev close
265.76
Day high
268.70
Day low
260.62
Volume
4.50M
Market cap
$471.27B
P/E (TTM)
75.34
52W range
190.75 – 269.39
Day trading desk
Gap from prior close
-0.04%
Prior close 265.76
VWAP
266.69
-0.00% from price
Relative volume
1.75×
Unusually busy
Session range
3.16%
260.62 – 268.86
Position in range
74%
Near session high
ATR (14D)
5.11
1.92% of price
Prior day high
267.34
PDH
Prior day low
260.29
PDL
Bid / ask spread
—
Quote not published
Session volume
8.60M
Avg 4.92M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.29%
-0.7%
1M
+3.99%
+2.8%
3M
+5.52%
+1.0%
6M
+29.23%
+11.0%
YTD
+16.72%
+2.5%
1Y
+14.01%
-2.4%
3Y
+78.91%
-3.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ABBV open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+12.30K
Net buying
Buy transactions
12
45.01K shares
Sell transactions
1
32.71K shares
Net transactions
+13
Buys less sells
Sell : buy shares
0.7 : 1
Mixed
Insider-held shares
1.94M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | DONOGHOE NICHOLAS Officer |
CONVERSION | 32.71K | $2.58M | Direct |
| Aug 14, 26 | DONOGHOE NICHOLAS Officer |
SELL | 32.71K | $8.18M | Direct |
| May 8, 26 | RAPP EDWARD J Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | WADDELL FREDERICK H Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | HART BRETT J Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | FREYMAN THOMAS C Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | FALK THOMAS J Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | AUSTIN ROXANNE SCHUH Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | QUAGGIN SUSAN E Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | BURNSIDE WILLIAM H L Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | DAVIS JENNIFER L Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | MEYER MELODY B Director |
STOCK | 1.12K | $0 | Direct |
| May 8, 26 | ROBERTS REBECCA B. Director |
STOCK | 1.12K | $0 | Direct |
| Mar 4, 26 | PURDUE DAVID RYAN Officer |
SELL | 5.23K | $1.22M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DONOGHOE NICHOLAS |
Officer | 74.43K | Conversion of Exercise of derivative security |
FREYMAN THOMAS C |
Director | 135.75K | Stock Award(Grant) |
GONZALEZ RICHARD A |
Director | 386.48K | Stock Gift |
MICHAEL ROBERT A. |
Chief Executive Officer | 215.26K | Stock Award(Grant) |
RAPP EDWARD J |
Director | 45.96K | Stock Award(Grant) |
REENTS SCOTT T. |
Chief Financial Officer | 60.41K | Stock Award(Grant) |
SALEKI-GERHARDT AZITA |
Chief Operating Officer | 220.68K | Stock Award(Grant) |
STEWART JEFFREY RYAN |
Officer | 108.32K | Stock Award(Grant) |
THAKKAR ROOPAL |
Officer | 60.41K | Stock Award(Grant) |
TILTON GLENN FLETCHER |
Director | 51.91K | Stock Award(Grant) |
Fundamentals
Market cap$471.27B
Enterprise value$535.64B
Revenue (TTM)$64.39B
Gross profit$46.87B
EBITDA$30.76B
Net income$6.27B
EPS (TTM)$3.54
Free cash flow$16.87B
Total cash$6.57B
Total debt$70.88B
Book value / share$-3.36
Shares outstanding1.77B
Float1.76B
Short % of float1.23%
Dividend yield2.60%
Beta (5Y)0.23
Valuation & profitability ratios
Trailing P/E75.34
Forward P/E16.40
PEG ratio0.54
Price / sales—
Price / book—
EV / revenue8.32
EV / EBITDA17.41
Gross margin72.79%
Operating margin40.03%
Profit margin9.80%
Return on equity—
Return on assets10.51%
Debt / equity—
Current ratio0.81
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $61.16B | $56.33B | $54.32B | $58.05B | +8.6% |
| Operating revenue | $61.16B | $56.33B | $54.32B | $58.05B | +8.6% |
| Cost of revenue | $18.20B | $16.90B | $20.41B | $17.41B | +7.7% |
| Gross profit | $42.96B | $39.43B | $33.90B | $40.64B | +8.9% |
| Research & development | $9.10B | $12.79B | $7.67B | $6.51B | -28.9% |
| Selling, general & admin | $14.01B | $14.75B | $12.87B | $15.26B | -5.0% |
| Total operating expense | $22.86B | $27.54B | $20.37B | $21.83B | -17.0% |
| Operating income | $20.09B | $11.89B | $13.54B | $18.81B | +68.9% |
| Net interest income | -$2.63B | -$2.16B | -$1.68B | -$2.04B | -21.6% |
| Pre-tax income | $6.60B | $3.72B | $6.25B | $13.48B | +77.5% |
| Tax provision | $2.36B | -$570.00M | $1.38B | $1.63B | +514.7% |
| Net income | $4.23B | $4.28B | $4.86B | $11.84B | -1.2% |
| Net income to common | $4.19B | $4.24B | $4.82B | $11.78B | -1.2% |
| Basic EPS | 2.39 | 2.42 | 2.75 | 6.69 | -1.4% |
| Diluted EPS | 2.36 | 2.39 | 2.72 | 6.63 | -1.3% |
| EBIT | $9.49B | $6.52B | $8.47B | $15.71B | +45.5% |
| EBITDA | $17.63B | $14.91B | $17.17B | $24.17B | +18.2% |
| Basic shares | 1.77B | 1.77B | 1.77B | 1.77B | +0.1% |
| Diluted shares | 1.77B | 1.77B | 1.77B | 1.78B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.23B | $5.52B | $12.81B | $9.20B | -5.3% |
| Cash & short-term investments | $5.26B | $5.55B | $12.82B | $9.23B | -5.4% |
| Accounts receivable | $12.59B | $10.92B | $11.15B | $11.25B | +15.3% |
| Inventory | $4.95B | $4.18B | $4.10B | $3.58B | +18.4% |
| Total current assets | $29.06B | $25.58B | $33.00B | $28.46B | +13.6% |
| Property, plant & equipment | $5.63B | $5.13B | $4.99B | $4.93B | +9.6% |
| Goodwill & intangibles | $88.28B | $95.02B | $87.90B | $99.59B | -7.1% |
| Total assets | $133.96B | $135.16B | $134.71B | $138.81B | -0.9% |
| Total current liabilities | $43.29B | $38.75B | $37.84B | $29.54B | +11.7% |
| Current debt | $8.55B | $6.80B | $7.19B | $4.14B | +25.7% |
| Long-term debt | $58.94B | $60.34B | $52.19B | $59.13B | -2.3% |
| Total debt | $67.50B | $67.14B | $59.38B | $63.27B | +0.5% |
| Total liabilities | $137.19B | $131.80B | $124.31B | $121.52B | +4.1% |
| Retained earnings | -$15.49B | -$7.90B | -$1.00B | $4.78B | -96.1% |
| Shareholder equity | -$3.27B | $3.33B | $10.36B | $17.25B | -198.3% |
| Working capital | -$14.23B | -$13.17B | -$4.84B | -$1.07B | -8.1% |
| Net tangible assets | -$91.55B | -$91.70B | -$77.54B | -$82.34B | +0.2% |
| Shares issued | 1.84B | 1.83B | 1.82B | 1.81B | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $4.23B | $4.29B | $4.87B | $11.85B | -1.2% |
| Depreciation & amortisation | $8.14B | $8.39B | $8.70B | $8.47B | -2.9% |
| Stock-based compensation | $955.00M | $911.00M | $747.00M | $671.00M | +4.8% |
| Change in working capital | -$2.36B | -$2.78B | $2.81B | -$94.00M | +15.1% |
| Operating cash flow | $19.03B | $18.81B | $22.84B | $24.94B | +1.2% |
| Capital expenditure | -$1.21B | -$974.00M | -$777.00M | -$695.00M | -24.6% |
| Investing cash flow | -$6.64B | -$20.82B | -$2.01B | -$623.00M | +68.1% |
| Share buybacks | -$980.00M | -$1.71B | -$1.97B | -$1.49B | +42.6% |
| Dividends paid | -$11.66B | -$11.03B | -$10.54B | -$10.04B | -5.7% |
| Financing cash flow | -$12.72B | -$5.21B | -$17.22B | -$24.80B | -144.2% |
| Free cash flow | $17.82B | $17.83B | $22.06B | $24.25B | -0.1% |
| End cash position | $5.23B | $5.52B | $12.81B | $9.20B | -5.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $16.99B | $15.00B | $16.62B | $15.78B | $15.42B | +13.3% |
| Operating revenue | $16.99B | $15.00B | $16.62B | $15.78B | $15.42B | +13.3% |
| Cost of revenue | $4.29B | $4.22B | $4.55B | $5.30B | $4.35B | +1.7% |
| Gross profit | $12.70B | $10.78B | $12.07B | $10.47B | $11.08B | +17.8% |
| Research & development | $2.34B | $2.47B | $2.58B | $2.32B | $2.13B | -5.2% |
| Selling, general & admin | $3.63B | $3.58B | $3.90B | $3.57B | $3.25B | +1.5% |
| Total operating expense | $5.98B | $6.05B | $6.26B | $5.89B | $5.36B | -1.2% |
| Operating income | $6.72B | $4.73B | $5.81B | $4.58B | $5.72B | +42.0% |
| Net interest income | -$679.00M | -$645.00M | -$655.00M | -$667.00M | -$678.00M | -5.3% |
| Pre-tax income | $4.28B | $1.04B | $2.67B | $714.00M | $1.55B | +311.7% |
| Tax provision | $662.00M | $342.00M | $853.00M | $526.00M | $613.00M | +93.6% |
| Net income | $3.61B | $695.00M | $1.82B | $186.00M | $938.00M | +419.9% |
| Net income to common | $3.60B | $685.00M | $1.81B | $176.00M | $928.00M | +425.7% |
| Basic EPS | 2.04 | 0.39 | 1.03 | 0.11 | 0.53 | +419.8% |
| Diluted EPS | 2.03 | 0.39 | 1.02 | 0.10 | 0.52 | +420.5% |
| EBIT | $5.02B | $1.76B | $3.38B | $1.45B | $2.29B | +186.1% |
| EBITDA | $6.91B | $3.69B | $5.37B | $3.52B | $4.34B | +87.1% |
| Basic shares | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | +0.0% |
| Diluted shares | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.57B | $9.39B | $5.23B | $5.63B | $6.47B | -30.1% |
| Cash & short-term investments | $6.57B | $9.39B | $5.26B | $5.67B | $6.47B | -30.1% |
| Accounts receivable | $13.82B | $12.48B | $12.59B | $12.77B | $12.64B | +10.8% |
| Inventory | $5.13B | $5.05B | $4.95B | $4.94B | $4.96B | +1.5% |
| Total current assets | $33.67B | $33.53B | $29.06B | $28.54B | $29.26B | +0.4% |
| Property, plant & equipment | $5.80B | $5.69B | $5.63B | $5.48B | $5.28B | +1.9% |
| Goodwill & intangibles | $84.66B | $86.44B | $88.28B | $89.94B | $92.67B | -2.1% |
| Total assets | $135.12B | $136.46B | $133.96B | $133.90B | $137.18B | -1.0% |
| Total current liabilities | $41.64B | $42.10B | $43.29B | $39.39B | $39.77B | -1.1% |
| Current debt | $8.34B | $8.33B | $8.55B | $5.77B | $7.52B | +0.2% |
| Long-term debt | $62.48B | $64.53B | $58.94B | $62.97B | $62.96B | -3.2% |
| Total debt | $70.82B | $72.86B | $67.50B | $68.74B | $70.48B | -2.8% |
| Total liabilities | $141.00B | $143.07B | $137.19B | $136.50B | $137.32B | -1.4% |
| Retained earnings | -$17.33B | -$17.87B | -$15.49B | -$14.23B | -$11.50B | +3.0% |
| Shareholder equity | -$5.93B | -$6.66B | -$3.27B | -$2.64B | -$183.00M | +10.8% |
| Working capital | -$7.97B | -$8.57B | -$14.23B | -$10.85B | -$10.51B | +7.0% |
| Net tangible assets | -$90.59B | -$93.10B | -$91.55B | -$92.58B | -$92.85B | +2.7% |
| Shares issued | 1.77B | 1.84B | 1.84B | 1.84B | 1.84B | -4.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $3.62B | $697.00M | $1.81B | $188.00M | $941.00M | +418.8% |
| Depreciation & amortisation | $1.88B | $1.94B | $1.99B | $2.06B | $2.05B | -2.7% |
| Stock-based compensation | $166.00M | $444.00M | $157.00M | $209.00M | $179.00M | -62.6% |
| Change in working capital | -$2.72B | -$1.92B | -$473.00M | $1.25B | -$562.00M | -41.6% |
| Operating cash flow | $3.44B | $3.83B | $5.22B | $7.02B | $5.15B | -10.3% |
| Capital expenditure | -$322.00M | -$265.00M | -$329.00M | -$381.00M | -$269.00M | -21.5% |
| Investing cash flow | -$1.20B | -$574.00M | -$1.46B | -$3.26B | -$1.18B | -108.5% |
| Share buybacks | -$9.00M | -$1.49B | -$3.00M | -$4.00M | -$12.00M | +99.4% |
| Dividends paid | -$3.07B | -$3.09B | -$2.91B | -$2.91B | -$2.91B | +0.5% |
| Financing cash flow | -$5.05B | $919.00M | -$4.17B | -$4.59B | -$2.71B | -649.9% |
| Free cash flow | $3.11B | $3.56B | $4.89B | $6.64B | $4.88B | -12.6% |
| End cash position | $6.57B | $9.39B | $5.23B | $5.63B | $6.47B | -30.1% |
Options analytics
Put / call volume
0.44
Call-heavy session
Put / call open interest
0.32
Positioning, not flow
Max pain
262.50
-1.6% from spot
ATM implied vol
33.2%
Nearest strike to spot
Skew (10% OTM)
-32.6%
Calls bid over puts
Call volume
1.55K
Contracts, this expiry
Put volume
686
Contracts, this expiry
Heaviest call OI
270.00
1.61K contracts
Heaviest put OI
255.00
488 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 3.61 | 3.65 | +1.2% |
| Mar 2026 | 2.67 | 2.65 | -0.8% |
| Dec 2025 | 2.65 | 2.71 | +2.2% |
| Sep 2025 | 1.78 | 1.86 | +4.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 3.83 | 15 | $17.31B | +9.7% |
| Next quarter | 3.86 | 15 | $18.32B | +10.2% |
| Current year | 13.88 | 7 | $67.60B | +10.5% |
| Next year | 16.23 | 26 | $73.50B | +8.7% |
Analyst targets & ownership
Mean target$280.29
High target$328.00
Low target$200.00
Implied upside5.10%
Analyst count28
ConsensusBUY
Strong buy / Buy8 / 16
Hold5
Sell / Strong sell0 / 1
Held by insiders0.11%
Held by institutions77.34%
Institutions holding5.24K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
264.09
+0.98% from price
SMA 20
262.45
+1.62% from price
SMA 50
258.17
+3.30% from price
SMA 100
246.21
+8.32% from price
SMA 200
231.94
+14.98% from price
EMA 12
263.66
+1.15% from price
EMA 26
261.73
+1.89% from price
EMA 50
257.52
+3.56% from price
RSI (14)
59.7
Neutral
MACD (12,26,9)
1.93
Hist -0.10
ATR (14)
5.11
1.92% of price
Realised vol 30D
16.7%
Annualised
Bollinger upper
270.24
20, 2σ
Bollinger lower
254.65
20, 2σ
50 / 200 cross
Golden
258.17 vs 231.94
Trend bias
Above 200
+14.98%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.11
Less volatile than market
Correlation to SPY
-0.06
Largely independent
Realised vol 30D
16.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-16.5%
Peak to trough
Max drawdown 5Y
-24.3%
Peak to trough
ATR 14
5.11
1.92% of price
Beta (reported)
0.23
5Y monthly, from filing
Short interest
Shares short
19.49M
Prior 18.30M
Change vs prior
+6.5%
Shorts adding
% of float
1.23%
Normal
% of shares out
1.10%
Against total outstanding
Days to cover
4.4
Liquid
Float
1.76B
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| Sep 10, 26 | HSBC | MAINTAINED | Buy | Buy |
| Aug 20, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 17, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 13, 26 | Wolfe Research | UPGRADE | Peer Perform | Outperform |
| Aug 11, 26 | BNP Paribas | MAINTAINED | Neutral | Neutral |
| Aug 10, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Berenberg | MAINTAINED | Buy | Buy |
| Aug 5, 26 | Erste Group | UPGRADE | Hold | Buy |
| Aug 4, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$6.92 / yr
Forward yield2.60%
5-year avg yield3.45%
Payout ratio190.40%
Ex-dividend dateOct 15, 2026
Next pay dateNov 16, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-05
Corporate Changes & Voting Matters
8-K · 2026-09-03
Corporate Changes & Voting Matters
8-K · 2026-08-18
Periodic Financial Reports
10-Q · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-07-06
Annual report of employee stock purchase
11-K · 2026-06-24
Corporate Changes & Voting Matters
8-K · 2026-06-22
Headlines
AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?
Insider Monkey · 1h ago
AbbVie Stocks Edge Higher as Lymphoma Trial Cuts Progression Risk 51%
GuruFocus.com · 6h ago
Forget Bonds: How Retirees Collect $6,650 a Month From Dividends Alone
24/7 Wall St. · 7h ago
3 of the Best Growth Stocks to Buy in October 2026
Motley Fool · 8h ago
HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English.
Motley Fool · 8h ago
Prediction: LLY Has Another Massive Growth Opportunity Beyond Weight Loss
24/7 Wall St. · 9h ago
European shares rise as retreating bond yields and oil prices boost risk appetite
Reuters · 9h ago
AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says
MT Newswires · 9h ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.